Home Country Focus Global Biotech’s decent start to 2018 PE, VC investing ends as value sinks...

Biotech’s decent start to 2018 PE, VC investing ends as value sinks to 12-month low

By

-

August 15, 2018

4639

Biotech’s decent start to the year in terms of private equity and venture capital invested faded away in July with

Technology partner